Anders Lundstrom is an experienced executive in the biopharmaceutical industry, currently serving as Chief Executive Officer and Board Member at Shield Therapeutics plc since May 2021, where Lundstrom also chairs the Remuneration Committee and is a member of the Strategic Opportunities Committee. Lundstrom holds the position of Interim CEO at EQT Group starting December 2023 and works as a Biopharma Consultant and Adviser with Lexington Biopharma Consulting LLC since July 2023. Previous roles include Chief Commercial Officer at Banner Life Sciences (March 2020 - June 2023) and SVP at Santhera Pharmaceuticals (June 2018 - April 2020), showcasing expertise in commercialization, product development, and patient insights. Lundstrom's extensive career includes leadership positions at EMD Serono, Orexo AB, Biogen Idec, and Astra Zeneca, complemented by a Master of Science degree in Pharmacy from Uppsala universitet.
This person is not in the org chart
This person is not in any teams
This person is not in any offices